Status:
COMPLETED
Chronic Pain Skills Study - Vanderbilt University Medical Center
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Osher Center for Integrative Medicine (OCIM) at Vanderbilt is a multidisciplinary outpatient clinic treating patients with chronic pain and complex health issues via integrative services, with goa...
Detailed Description
The purpose of this pilot project is to test the efficacy and mechanisms of clinical hypnosis on chronic pain. Primary (characteristic pain intensity) and secondary (mood, quality of life) outcomes wi...
Eligibility Criteria
Inclusion
- 18 years of age or older; \*
- Self-reported presence of chronic pain;\*\*
- Average pain intensity rating of ≥ 3 on a 0-10 Numerical Rating Scale (NRS) of pain intensity in the last week; \*\*
- Worst pain intensity rating of ≥ 5 on a 0-10 Numerical Rating Scale (NRS) of pain intensity in the last week;\*\*
- Duration of chronic pain 3 months or more; \*\*
- Experiences pain at least 75% of the time in the past 3 months; Those who have a hard time answering this question will be asked the following question: "Which statement best describes your pain?"
- Pain all the time, but the pain intensity varies;
- Pain most of the time with only occasional periods of being pain-free;
- Pain that comes and goes;
- Occasional pain; Participants must report experiencing pain that matches one of the first two options;\*\*
- Able to read, speak, and understand English.\*\*
Exclusion
- Cognitive impairment or limitations (i.e. history of moderate to severe Traumatic Brain Injury (TBI), unresolved TBI, or other medical condition) that would interfere with a patient's ability to participate in a group involving focused attention\*.
- Current or history of diagnosis of primary psychotic or major thought disorder as listed in participant's medical record or self-reported within the past five years;\*
- Hospitalization for psychiatric reasons other than suicidal ideation, homicidal ideation, and/or PTSD self-reported or noted in chart (within the past 5 years);\*
- Psychiatric or behavioral conditions in which symptoms are unstable or severe (e.g. current delirium, mania, psychosis, suicidal ideation, homicidal ideation, substance abuse dependency) as listed in participant's medical record or self-reported within the past six months;\*
- Any behavioral issues as noted in the medical record or by a provider that would indicate the participant may be inappropriate in a group setting;\*\*\*
- Presenting symptoms at time of screening that would interfere with participation, specifically active suicidal ideation with intent to harm oneself or active delusional or psychotic thinking;\*\*
- Difficulties or limitations communicating over the telephone;\*\*
- Any planned life events that would interfere with participating in the key elements of the study.\*\*
- Reported average daily use of \>120mg morphine equivalent dose (MED). \*\*
- also verified via medical record review, as described below. \*\*verified solely via self-report, as described below; there is no medical record
Key Trial Info
Start Date :
June 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2020
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT03384953
Start Date
June 22 2017
End Date
March 13 2020
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osher Center for Integrative Medicine at Vanderbilt
Nashville, Tennessee, United States, 37203